“…The selectivity of CMS membranes can be adjusted by controlling the cross-linking degree and pore size of the membranes. 35,142 Recently, Li et al first introduced 6,6′-15(1,4-phenylenebis) (((4-hydroxyphenyl) amino)methylene)bis(dibenzo[ c , e ][1,2] oxaphosphinine6-oxide, DOPO-p-DP) as a cross-linking agent to crosslink 6FDA-DAM-Br-85% PI, followed by carbonizing the obtained crosslinked precursor to form CMS membranes (Fig. 23a).…”